Frank Stinchfield award: Titanium surface with biologic activity against infection

Clinical Orthopaedics and Related Research

Volumn 429, Issue , 2004, Pages 33-38

  Parvizi, Javad ^a   Wickstrom, Eric ^a   Zeiger, Allen R ^a   Adams, Christopher S ^a   Shapiro, Irving M ^a   Purtill, James J ^a   Sharkey, Peter F ^a,b   Hozack, William J ^a,b   Rothman, Richard H ^a,b   Hickok, Noreen J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Stryker Orthopaedics

Author keywords

[No Author keywords available]

Indexed keywords

TITANIUM; VANCOMYCIN; BIOMATERIAL;

ARTHROPLASTY; BACTERICIDAL ACTIVITY; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; PRIORITY JOURNAL; PROSTHESIS INFECTION; SYNTHESIS; ARTICLE; AWARDS AND PRIZES; BIOFILM; COMPARATIVE STUDY; DRUG EFFECT; HIP PROSTHESIS; HUMAN; INFECTION; KNEE PROSTHESIS; MATERIALS TESTING; METHODOLOGY; PROBABILITY; PROSTHESIS; SENSITIVITY AND SPECIFICITY; SURFACE PROPERTY;

AWARDS AND PRIZES; BIOFILMS; COATED MATERIALS, BIOCOMPATIBLE; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; MATERIALS TESTING; PROBABILITY; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; SENSITIVITY AND SPECIFICITY; SURFACE PROPERTIES; TITANIUM; VANCOMYCIN;

EID: 16644402333     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000150116.65231.45     Document Type: Conference Paper

References (45)

1. Adams K, Couch L, Cierny G, Calhoun J, Mader JT: In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop 278:244-252, 1992.
2. American Academy of Orthopedic Surgeons: Burden of the Disease. Official Publication for Bone and Joint Decade. American Academy of Orthopaedic Surgeons 2002.
3. Aughenbaugh W, Radin S, Ducheyne P: Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vanomycin. J Biomed Mater Res 57:321-326, 2001.
4. Barrack R: Economics of revision total hip arthroplasty. Clin Orthop 319:209-214, 1995.
5. Berbari EF, Hanssen AD, Duffy MC, et al: Risk factors for prosthetic joint infection: Case-control study. Clin Infect Dis 27:1247-1254, 1998.
6. Brandt CM, Sistrunk WW, Duffy MC, et al: Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 24:914-919, 1997.
7. Cavalcanti-Adam EA, Shapiro IM, Composto RJ, Macarak EJ, Adams CS: RGD peptides immobilized on a mechanically deformable surface promote osteoblast differentiation. J Bone Miner Res 17: 2130-2140, 2002.
8. Chao W, Lin SS, Charleton WH, Shah SA, Tuan RS: Biodegradable drug delivery system applied onto fracture fixation plates and intramedullary rods: In vivo comparative analysis. Trans Orthop Res Soc 41:299, 1995.
9. Charnley J, Eftekhar N: Postoperative infection in total prosthetic replacement arthroplasty of the hip joint with special reference to the bacterial content of the air in the operating room. Br J Surg 56: 641-649, 1969.
10. Cierny III G, DiPasquale D: Periprosthetic total joint infections: Staging, treatment, and outcomes. Clin Orthop 403:23-28, 2002.
11. Classen DC, Evans RS, Pestomik SL, et al: The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 326:281-286, 1992.
12. Ducheyne P, Martens M, Burssens A: Materials, clinical and morphological evaluation of custom-made bioreactive-glass-coated canine hip prostheses. J Biomed Mater Res 18:1017-1030, 1984.
13. Duncan CP, Masri BA: The role of antibiotic-loaded cement in the treatment of an infection after a hip replacement. Instr Course Lect 44:305-313, 1995.
14. Falaize S, Radin S, Ducheyne P: In vitro behavior of silica-based xerogels intended as controlled release carriers. Journal of American Ceramic Society 82:969-976, 1999.
15. Filiaggi M, Pilliar R, Abdulla D: Evaluating sol-gel ceramic thin films for metal implant applications. II. Adhesion and fatigue properties of zirconia films on Ti 6AI-4V. J Biomed Mater Res 33:239-256, 1996.
16. Fitzgerald Jr RH: Total hip arthroplasty. Prevention and diagnosis. Orthop Clin North Am 23:259-264, 1992.
17. Frazier DD, Lathi VK, Gerhart TN, Hayes WC: Ex vivo degradation of a poly(propylene glycol-fumarate) biodegradable particulate composite bone cement. J Biomed Mater Res 35:383-389, 1997.
18. Garvin KL, Robinson DN, Sampath S, Giger D, Beck S: Treatment of canine osteomyelitis with a biodegradable antibiotic implant. Trans Orthop Res Soc 17:437, 1992.
19. Garvin KL, Hanssen AD: Infection after total hip arthroplasty: Past, present, and future. J Bone Joint Surg 77A:1576-1588, 1995.
20. Gillespie WJ: Prevention and management of infection after total joint replacement. Clin Infect Dis 25:1310-1317, 1997.
21. Haddad FS, Masri BA, Campbell D, et al: The PROSTALAC functional spacer in two-stage revision for infected knee replacements. Prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg 82B:807-812, 2000.
22. Hanssen AD, Osmon DR, Nelson CL: Prevention of deep periprosthetic joint infection. Instr Course Lect 46:555-567, 1997.
23. Henry SL, Seligsobn D, Mangino P, Pophom GJ: Antibiotic impregnated beads. Part I. Bead implantation versus systemic therapy. Orthop Rev 20:242-247, 1991.
24. Herbert CK, Williams RE, Levy RS, Barrack RL: Cost of treating an infected total knee replacement. Clin Orthop 331:140-145, 1996.
25. Hill C, Flamant R, Mazas F, Evard J: Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blinded radomised trial. Lancet 1:795-797, 1981.
26. Holtom PD, Patzakis MJ: Newer methods of antimicrobial delivery for bone and joint infections. Instr Course Lect 52:745-749, 2003.
27. Ikada Y, Hyon SH, Jamshidi K, et al: Release of antibiotic from composite of hydroxyapatite and poly (lactic acid). J Control Release 2:179-186, 1985.
28. Josefsson G, Gudmundsson G, Kolmert L, Wijkstrom S: Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A five-year survey of 1688 hips. Clin Orthop 253:173-178, 1990.
29. Kanellakopoulou K, Giamarellos-Bourboulis EJ: Carrier systems for the local delivery of antibiotics in bone infections. Drugs 59: 1223-1232, 2000.
30. Kendall RW, Duncan CP, Beauchamp CP: Bacterial growth on antibiotic-loaded acrylic cement. A prospective in vivo retrieval study. J Arthroplasty 10:817-822, 1995.
31. Kendall RW, Duncan CP, Smith JA, Ngui-Yen JH: Persistence of bacteria on antibiotic loaded acrylic depots. A reason for caution. Clin Orthop 329:273-280, 1996.
32. Korkusuz F, Korkusuz P, Ekiolu F, Gursel I, Hasirci V: In vivo response to biodegradable controlled antibiotic release systems. J Biomed Mater Res 55:217-228, 2001.
33. Kuechle DK, Landon GC, Musher DM, Noble PC: Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop 302-308, 1991.
34. Lawrence RC, Helmick CG, Arnett FC, et al: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778-799, 1998.
35. Nestor BJ, Hanssen AD, Ferrer-Gonzalez R, Fitzgerald Jr RH: The use of porous prostheses in delayed reconstruction of total hip replacements that have failed because of infection. J Bone Joint Surg 76A:349-359, 1994.
36. Peersman G, Laskin R, Davis J, Peterson M: Infection in total knee replacement: A retrospective review of 6489 total knee replacements. Clin Orthop 392:15-23, 2001.
37. Price JS, Tencer AF, Arm DM, Bohach GA: Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res 30:281-286, 1996.
38. Radin S, Ducheyne P, Kamplain T, Tan BH: Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. J Biomed Mater Res 57:313-320, 2001.
39. Salvati EA, Gonzalez Della Valle A, Masri BA, Duncan CP: The infected total hip arthroplasty. Instr Course Lect 52:223-245, 2003.
40. Sculco TP: The Economic Impact of Infected Total Joint Arthroplasty. In Heckman JD (ed). American Academy of Orthopaedic Surgeons, Instructional Course Lectures. Rosemont, IL: American Academy of Orthopaedic Surgeons 42:349-351, 1993.
41. Spangehl MJ, Younger AS, Masri BA, Duncan CP: Diagnosis of infection following total hip arthroplasty. Instr Course Lect 47:285-295, 1998.
42. Suzuki Y, Tanihara M, Nishimura Y, et al: A new drug delivery system with controlled release of antibiotic only in the presence of infection. J Biomed Mater Res 42:112-116, 1998.
43. Trippel SB: Antibiotic-impregnated cement in total joint arthroplasty. J Bone Jont Surg. 68A:1297-1302, 1986.
44. Wentworth SJ, Masri BA, Duncan CP, Southworth CB: Hip prosthesis of antibiotic-loaded acrylic cement for the treatment of infections following total hip arthroplasty. J Bone Joint Surg 84A (Suppl 2):123-128, 2002.
45. Windsor RE, Insall JN: Management of Infected Total Knee arthroplasty. In Insall JN (ed). Surgery of the Knee. Ed 2. New York, Churchill Livingstone 962, 1993.